Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancerUENO, Hideki; OKUSAKA, Takuji; IKEDA, Masafumi et al.Oncology. 2004, Vol 67, Num 3-4, pp 215-221, issn 0030-2414, 7 p.Article

Chemotherapy for biliary tract cancer in JapanOKUSAKA, Takuji.Seminars in oncology. 2002, Vol 29, Num 6, pp 51-53, issn 0093-7754, 3 p., SUP20Conference Paper

Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapyUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Oncology. 2000, Vol 59, Num 4, pp 296-301, issn 0030-2414Article

Phase II study of uracil-tegafur in patients with metastatic pancreatic cancerUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Oncology. 2002, Vol 62, Num 3, pp 223-227, issn 0030-2414Article

An early phase II study of S-1 in patients with metastatic pancreatic cancerUENO, Hideki; OKUSAKA, Takuji; IKEDA, Masafumi et al.Oncology. 2005, Vol 68, Num 2-3, pp 171-178, issn 0030-2414, 8 p.Article

Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapySAISHO, Toshimitsu; OKUSAKA, Takuji; UENO, Hideki et al.Hepato-gastroenterology. 2005, Vol 52, Num 66, pp 1654-1658, issn 0172-6390, 5 p.Article

Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapyIKEDA, Masafumi; OKADA, Shuichi; TOKUUYE, Koichi et al.Cancer. 2001, Vol 91, Num 3, pp 490-495, issn 0008-543XArticle

Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma : outcomes and the associated elevation of alpha-fetoproteinTAKAYASU, Kenichi; MURAMATSU, Yukio; MIZUGUCHI, Yasunori et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 1, pp 288-294, issn 0815-9319, 7 p., 2Article

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinomaIKEDA, Masafumi; OKUSAKA, Takuji; UENO, Hideki et al.Cancer. 2005, Vol 103, Num 4, pp 756-762, issn 0008-543X, 7 p.Article

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinomaUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Cancer chemotherapy and pharmacology. 2002, Vol 49, Num 2, pp 155-160, issn 0344-5704Article

Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injectionKUUIYAMA, Hitoshi; OKADA, Shuichi; OKUSAKA, Takuji et al.Journal of gastroenterology and hepatology. 2002, Vol 17, Num 11, pp 1205-1210, issn 0815-9319, 6 p.Article

A late phase II study of S-1 for metastatic pancreatic cancerOKUSAKA, Takuji; FUNAKOSHI, Akihiro; FURUSE, Junji et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 4, pp 615-621, issn 0344-5704, 7 p.Article

FP Therapy for Controlling Malignant Ascites in Advanced Pancreatic Cancer PatientsYONEMORI, Kan; OKUSAKA, Takuji; UENO, Hideki et al.Hepato-gastroenterology. 2007, Vol 54, Num 80, pp 2383-2386, issn 0172-6390, 4 p.Article

Phase II Study of Cisplatin, Epirubicin and Continuous Infusion of 5-Fluorouracil in Patients with Advanced Intrahepatic Cholangiocellular Carcinoma (ICC)TAKEZAKO, Yoriko; OKUSAKA, Takuji; UENO, Hideki et al.Hepato-gastroenterology. 2008, Vol 55, Num 85, pp 1380-1384, issn 0172-6390, 5 p.Article

Hepatic Arterial Infusion Chemotherapy with Epirubicin in Patients with Advanced Hepatocellular Carcinoma and Portal Vein Tumor ThrombosisIKEDA, Masafumi; OKUSAKA, Takuji; UENO, Hideki et al.Oncology. 2007, Vol 72, Num 3-4, pp 188-193, issn 0030-2414, 6 p.Article

Predictive factors for tumor response to chemotherapy in patients with pancreatic cancerFUJISHIRO, Mitsuhiro; OKADA, Shuichi; UENO, Hideki et al.Hepato-gastroenterology. 2000, Vol 47, Num 36, pp 1744-1746, issn 0172-6390Article

Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancerFURUSE, Junji; OKUSAKA, Takuji; BRIDGEWATER, John et al.Critical reviews in oncology/hematology. 2011, Vol 80, Num 1, pp 31-39, issn 1040-8428, 9 p.Article

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer : a multicenter phase II studyFURUSE, Junji; OKUSAKA, Takuji; BOKU, Narikazu et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 849-855, issn 0344-5704, 7 p.Article

CT evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver diseaseTAKAYASU, Kenichi; MURAMATSU, Yukio; MIZUGUCHI, Yasunori et al.American journal of roentgenology (1976). 2006, Vol 187, Num 2, pp 454-463, issn 0361-803X, 10 p.Article

Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injectionUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Hepato-gastroenterology. 2001, Vol 48, Num 41, pp 1430-1434, issn 0172-6390Article

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerMORIZANE, Chigusa; OKUSAKA, Takuji; FURUSE, Junji et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 313-319, issn 0344-5704, 7 p.Article

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancerSUZUKI, Eiichiro; IKEDA, Masafumi; OKUSAKA, Takuji et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 5, pp 1141-1146, issn 0344-5704, 6 p.Article

Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinomaOKUSAKA, Takuji; OKADA, Shuichi; UENO, Hideki et al.Oncology. 2002, Vol 62, Num 3, pp 228-233, issn 0030-2414Article

A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancerFURUSE, Junji; OKUSAKA, Takuji; OHKAWA, Shinichi et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 113-120, issn 0344-5704, 8 p.Article

Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment?HASHIMOTO, Kenji; UENO, Hideki; IKEDA, Masafumi et al.Oncology. 2009, Vol 77, Num 3-4, pp 217-223, issn 0030-2414, 7 p.Article